Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash $ 219,023 $ 3,523
Investment in Mutual Funds 1,001,000
Prepaid Expenses 215,040
Total current assets 1,435,063 3,523
Other noncurrent assets 76,777
Deferred offering costs 30,000
Cash and Investments held in Trust Account 300,017,634
Total Assets 301,529,474 33,523
Current liabilities:    
Accrued offering costs and expenses 259,390
Due to related party 30,000
Promissory note - related party 9,284
Total current liabilities 289,390 9,284
Warrant liability 6,853,000
Deferred underwriting fee 10,500,000
Total liabilities 17,642,390 9,284
Commitments
Common Stock subject to possible redemption, 30,000,000 and no shares at redemption value at September 30, 2021 and December 31, 2020, respectively 300,000,000
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 800,000 and 0 shares issued and outstanding (excluding 30,000,000 and no shares subject to possible redemption) at September 30, 2021 and December 31, 2020, respectively 80
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,500,000 and 7,618,750 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively [1] 750 762
Additional paid-in capital 24,238
Accumulated deficit (16,113,746) (761)
Total stockholders’ equity (deficit) (16,112,916) 24,239
Total Liabilities and Stockholders’ Equity $ 301,529,474 $ 33,523
[1] Shares at December 31, 2020 included up to 993,750 founder Class B shares subject to forfeiture by the Sponsor if over-allotment option was not exercised in full or in part by the underwriters (see Note 6).